Difficulty: Medium
Average Score: 68%
Practice
Which is the drug of choice for empirical treatment of a first episode of acute otitis media?
Correct answer
A
Rationale
In pediatric nursing, the drug of choice for empirical treatment of a first episode of acute otitis media is Amoxicillin. This choice is based on several factors that make Amoxicillin the preferred option. Firstly, Amoxicillin is effective against the most common pathogens causing otitis media in children, mainly Streptococcus pneumoniae and Haemophilus influenzae. It has a good safety profile, is well-tolerated by children, and has a narrow spectrum of activity, reducing the risk of antibiotic resistance.
Trimethoprim-sulfamethoxazole (B) is not recommended as a first-line treatment for acute otitis media due to increasing resistance rates among common pathogens. Amoxicillin-clavulanate (C) is reserved for cases where the child has recently received antibiotics or if there is a suspicion of resistant pathogens. Ceftriaxone (D) is usually reserved for severe cases or when the child cannot tolerate oral medications.
In an educational context, understanding the rationale behind choosing Amoxicillin for acute otitis media in children is crucial for nursing students and healthcare professionals. It reinforces the importance of evidence-based practice, antibiotic stewardship, and considering factors such as efficacy, safety, and resistance patterns when making treatment decisions for pediatric patients.
Trimethoprim-sulfamethoxazole (B) is not recommended as a first-line treatment for acute otitis media due to increasing resistance rates among common pathogens. Amoxicillin-clavulanate (C) is reserved for cases where the child has recently received antibiotics or if there is a suspicion of resistant pathogens. Ceftriaxone (D) is usually reserved for severe cases or when the child cannot tolerate oral medications.
In an educational context, understanding the rationale behind choosing Amoxicillin for acute otitis media in children is crucial for nursing students and healthcare professionals. It reinforces the importance of evidence-based practice, antibiotic stewardship, and considering factors such as efficacy, safety, and resistance patterns when making treatment decisions for pediatric patients.